Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 34.19
+1.92 (5.95%)
At close: Mar 6, 2026
SHA:688062 Revenue
In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M CNY with 231.62% growth. Mabwell (Shanghai) Bioscience had revenue of 96.68M in the quarter ending December 31, 2025, with 64.74% growth.
Revenue
662.52M
Revenue Growth
+231.62%
P/S Ratio
20.61
Revenue / Employee
467.88K
Employees
1,362
Market Cap
13.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 662.52M | 462.73M | 231.62% |
| Dec 31, 2024 | 199.78M | 71.95M | 56.28% |
| Dec 31, 2023 | 127.84M | 100.11M | 361.03% |
| Dec 31, 2022 | 27.73M | 11.50M | 70.88% |
| Dec 31, 2021 | 16.23M | 10.92M | 206.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition